Bulk and Wholesale Laboratory Enquiries
A useful wholesale enquiry states the purchasing organisation, research purpose, exact sequence or catalogue item, quantity, target purity, required analytical methods, packaging format, delivery window and documentation standard. Sterling reviews feasibility and compliance before quoting. A quotation is not acceptance, reservation of stock or permission for prohibited use.
When to use the wholesale route
Use a wholesale enquiry when the project needs quantities, packaging, analytical evidence, delivery terms or procurement documents beyond the standard catalogue. It is also appropriate for repeat schedules, multi-site research, custom sequences or institutional purchase-order review.
Do not split a bulk requirement across many retail orders to avoid discussion. That can fragment traceability and prevent the supplier from assessing feasibility, batch capacity, packaging and compliance. One structured request creates a clearer record.
Organisation and project information
Identify the legal purchasing entity, institution type, website, billing address, delivery site and authorised procurement contact. Provide a technical contact who can answer specification questions. If the work is funded or conducted for another organisation, explain the relationship where relevant to supply review.
Describe the research purpose at a level sufficient to confirm laboratory use. Do not include patient data or confidential protocol detail that is unnecessary for procurement. State the facility type and whether special permits, ethics approvals or import documents affect the order.
Sterling may conduct business, sanctions, fraud, address and end-use checks. A request can be declined when the organisation or purpose cannot be verified or conflicts with the Research Use Only policy.
Define the material
For a catalogue item, provide product name, SKU, variation and required quantity. For custom work, provide the complete sequence, termini, stereochemistry, disulfide connectivity, modifications, labels, conjugates and desired salt or counter-ion. Attach a controlled specification rather than relying on an email nickname.
State whether quantity means gross lyophilised mass, net peptide content, molar amount, number of vials or another basis. Define fill tolerance and whether excipients are permitted. If exact content is critical, request an appropriate quantitative assay.
For terms such as TB-500 that can be chemically ambiguous, the sequence is mandatory. Literature relevance and pricing cannot be assessed until the test material is defined.
Purity and analytical package
State the target purity and how it should be measured. A percentage without a method can be disputed. Define whether a batch chromatogram, method summary, raw data or independent laboratory report is required.
Identity evidence may include mass spectrometry, peptide mapping, amino-acid analysis or another orthogonal method. Additional attributes can include water, counter-ion, residual solvents, elemental impurities, bioburden, endotoxin or sterility where scientifically and operationally appropriate.
Not every test is available, validated or meaningful for every material. Sterling will review feasibility and should identify methods, laboratories, reporting basis and acceptance limits in the quotation. Review the quality assurance hub before drafting requirements.
Packaging and labelling
Specify vial material, closure, fill size, number of units, secondary containment and label fields. Consider how the receiving laboratory will sample material and control freeze-thaw cycles. A lower number of large vials may reduce packaging cost but increase handling risk.
Labels should include enough information to maintain identity and batch traceability. If the institution needs an internal item code, barcode or purchase-order reference, describe the format. Additional labelling must not obscure mandatory supplier information or misrepresent the material.
Custom packaging can require development time, minimum quantities and compatibility review. Include transport orientation, tamper evidence and desiccation requirements where relevant.
Delivery and cold-chain requirements
Provide destination, receiving hours, access restrictions, requested delivery window and storage capability. State whether split delivery or a single batch is required. For international destinations, identify the importer of record and confirm that procurement and import are permitted.
If controlled temperature is critical, define the acceptable range, maximum duration, logger, packaging qualification and excursion process. “Ship cold” is not a complete requirement. See the shipping policy.
Delivery dates remain estimates until stock, production, testing and carrier arrangements are confirmed. Build contingency into the project plan and avoid scheduling an irreversible experiment around an unaccepted quotation.
Documents and quality agreement
List the documents required before shipment, with shipment and after delivery. These can include quotation, order acknowledgement, invoice, packing list, CoA, chromatograms, mass spectrum, safety information and origin documents.
For sustained or high-value supply, a quality agreement can define responsibilities for specifications, testing, release, changes, deviations, complaints, recalls, retained samples and records. It should align with the actual services and regulatory status; copying a pharmaceutical quality agreement onto research supply can create false obligations.
State whether the organisation requires supplier questionnaires, audits or approved-vendor onboarding. Allow realistic review time.
Pricing and quotation structure
A quotation should identify material, quantity, unit basis, tests, packaging, price, tax, delivery, payment terms, lead time, validity and exclusions. Custom work may include non-recurring development or method charges. Ask whether failed synthesis, out-of-specification material or partial yield changes cost and delivery.
Price should not be separated from acceptance criteria. Higher purity, difficult sequences, specialist packaging and independent testing can change feasibility and cost significantly.
A quotation is an offer for review, not automatic order acceptance or stock reservation. Acceptance occurs under the final laboratory supply terms and documented order process.
Purchase orders and invoices
Institutional purchase orders should reference the accepted quotation and match legal entity, currency, tax and delivery details. Conflicting standard terms should be resolved before acceptance. Do not assume that sending a purchase order overrides the supplier’s research-use restrictions.
Credit terms require approval. New organisations may be asked for advance payment or processor verification. The payment page explains secure handling and why card information must not be emailed.
Retain order, invoice, CoA and delivery records under the institution’s procurement and research-retention policies.
Change control and repeat supply
Repeat orders can involve a new batch, synthesis run, test method or packaging component. Define which changes require notification and whether bridging data are needed. Do not assume a catalogue code guarantees indefinite process equivalence.
Forecasts help capacity planning but are not firm orders unless stated. Distinguish expected annual use from committed quantity and define cancellation or rescheduling rights.
When consistent longitudinal work matters, discuss batch reservation, retained samples and storage. These services require written scope and may carry additional cost.
Supplier onboarding and due diligence
Procurement teams may request insurance, company records, bank verification, modern-slavery statements, information-security details or quality questionnaires. Identify mandatory items early and use secure channels for sensitive documents. Sterling should answer only from verified current records and should not select flattering answers that are unsupported by the operating system.
The purchaser should perform reciprocal due diligence. Verify that quotations and payment instructions originate from the expected domain and legal entity. Independently confirm any unexpected bank-detail change before sending funds. Establish who can approve specifications, deviations and delivery changes on both sides.
Where an audit is proportionate, agree scope, confidentiality, timing and follow-up. An audit can examine relevant controls, but it does not transfer the purchaser’s responsibility for defining the material and accepting the batch.
Enquiry checklist
- Purchasing organisation, billing and delivery contacts.
- Research purpose and institutional status.
- Catalogue SKU or exact custom sequence and molecular form.
- Quantity basis, fill size and schedule.
- Purity, identity and additional analytical requirements.
- Packaging, label, storage and transport conditions.
- Required records, supplier onboarding and quality agreement needs.
- Target date, budget assumptions, tax and payment process.
Send the completed request through the technical support desk. Do not include personal-use instructions or unnecessary sensitive data. Sterling will confirm what can be quoted and may request clarification before proceeding.
